Clinical Trials

230 enrolled

Uterine Cervical Dysplasia

NCT07520188 2026-04-09

CASCADE3002

Not yet recruiting

103 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01989923 2026-04-07

Smoking Cessation in Women With Gynecological Conditions

31 enrolled

Vaping, Uterine Cervical Dysplasia, Smoking Cessation

NCT04226313 2026-03-23

KOPRETINA

15,000 enrolled

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06810427 2026-03-18

CervImage

18 enrolled

Uterine Cervical Dysplasia

NCT07468695 2026-03-12

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

300 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07461818 2026-03-11

POC

5,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04712851 2026-03-10

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Phase 2 Recruiting

25 enrolled

Phase 2 Not yet recruiting

Uterine Cervical Dysplasia

NCT07454915 2026-03-09

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

138 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Uterine Cervical Dysplasia

NCT07429071 2026-03-04

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

70 enrolled

Uterine Cervical Dysplasia

NCT07372248 2026-03-02

Thermal Artifact in Patients Undergoing Conization: A Clinical Study

150 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05774561 2026-02-12

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Recruiting

480 enrolled

GynecologicHead & Neck

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT05870787 2026-02-10

MEDIATOR

929 enrolled

Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02749110 2026-02-05

PaCUDAHL-Gé

308 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Patient Compliance

NCT07390916 2026-02-05

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda

300 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07385976 2026-02-04

The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

Not yet recruiting

100 enrolled

Phase EARLY_PHASE1 Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT02554344 2026-01-30

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

Uterine Cervical Dysplasia

NCT07244315 2026-01-21

Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology

500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT07240220 2026-01-15

Merck-4

2,500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01639820 2025-12-19

SENTICOL2

267 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07275333 2025-12-18

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

1,000 enrolled

Phase 2 Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT06519994 2025-12-17

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

120 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07259616 2025-12-02

Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities

46,079 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07250841 2025-11-28

Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women

984 enrolled

Phase 3 Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04537156 2025-11-21

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

9,327 enrolled

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata

NCT06582004 2025-11-19

Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1

50 enrolled

Uterine Cervical Dysplasia

NCT05509413 2025-11-18

HPV-VG1

242 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06191133 2025-10-02

Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma

Phase 1 Recruiting

24 enrolled

Uterine Cervical Dysplasia

NCT05606133 2025-09-23

Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers

100 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT07146152 2025-08-28

Empowering Women - Shared Decision Making in Managing Cervical Precancer

138 enrolled

Uterine Cervical Dysplasia

NCT04131413 2025-08-24

HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Phase 1 Recruiting

48 enrolled

GynecologicOther neoplasm

Uterine Cervical Dysplasia

NCT06165614 2025-08-19

Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya

Phase 1 Completed

17 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT06263582 2025-08-19

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

Phase 1 Completed

12 enrolled 18 charts

GynecologicLymphoid

Carcinoma in Situ, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphoma, Follicular

NCT07059819 2025-08-13

Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection

Phase NA Enrolling by invitation

400 enrolled

Uterine Cervical Dysplasia

NCT06086054 2025-08-05

Effect of a Childcare Resource on Cervical Cancer Prevention

Phase NA Terminated

65 enrolled

Uterine Cervical Dysplasia

NCT06243666 2025-07-31

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Active not recruiting

2,188 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04788849 2025-07-29

Ext-VALHUDES

300 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03429582 2025-07-17

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

1,154 enrolled

Uterine Cervical Dysplasia

NCT02140021 2025-07-14

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Phase NA Terminated

409 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06054841 2025-06-29

Reshaping Postpartum Follow-up

157 enrolled

Uterine Cervical Dysplasia, Eclampsia, Pre-Eclampsia, Diabetes, Gestational, Hypertension, Pregnancy-Induced

NCT03542513 2025-06-13

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

65 enrolled

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05996783 2025-06-13

ScreenUrSelf

48,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03061435 2025-05-16

Vulvar-AIN

GastrointestinalGynecologic

110 enrolled

Anus Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT04278326 2025-04-20

ORGANOIDES

Phase NA Terminated

14 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT05266898 2025-04-18

AGO-Gard

Phase 4 Recruiting

250 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT03267680 2025-04-13

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Phase 2 Terminated

10 enrolled 19 charts

Uterine Cervical Dysplasia

NCT06915779 2025-04-08

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

241 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

NCT03084081 2025-04-06

UH3

1,132 enrolled 9 charts